{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:42:01Z","timestamp":1775796121952,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,17]]},"DOI":"10.7759\/cureus.79190","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T04:21:11Z","timestamp":1739852471000},"source":"Crossref","is-referenced-by-count":2,"title":["Views of the Public and Healthcare Professionals on Newborn Screening for Spinal Muscular Atrophy and the Potential for Detecting Adult-Onset Types in Patients-in-Waiting in Hong Kong"],"prefix":"10.7759","author":[{"given":"Chloe M","family":"Mak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacky Kwan Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy Chi Lap","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Yiu","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Hei Toby","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Wing","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Hau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophelia Hoi Shan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens","volume":"20","author":"Sugarman EA","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, et al.. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of &gt;72,400 specimens. Eur J Hum Genet. 2012, 20:27-32. 10.1038\/ejhg.2011.134","journal-title":"Eur J Hum Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart IE","year":"2017","unstructured":"Verhaart IE, Robertson A, Wilson IJ, et al.. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017, 12:10.1186\/s13023-017-0671-8","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","article-title":"Deaths: preliminary data for 2008","volume":"59","author":"Mini\u00f1o AM","year":"2010","unstructured":"Mini\u00f1o AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep. 2010, 59:1-52.","journal-title":"Natl Vital Stat Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7030033","article-title":"Landscape of spinal muscular atrophy newborn screening in the United States: 2018-2021","volume":"7","author":"Hale K","year":"2021","unstructured":"Hale K, Ojodu J, Singh S. Landscape of spinal muscular atrophy newborn screening in the United States: 2018-2021. Int J Neonatal Screen. 2021, 7:10.3390\/ijns7030033","journal-title":"Int J Neonatal Screen"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2023.34","article-title":"Variability in newborn screening across Canada: spinal muscular atrophy and beyond","volume":"51","author":"Groulx-Boivin E","year":"2024","unstructured":"Groulx-Boivin E, Osman H, Chakraborty P, et al.. Variability in newborn screening across Canada: spinal muscular atrophy and beyond. Can J Neurol Sci. 2024, 51:203-9. 10.1017\/cjn.2023.34","journal-title":"Can J Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99496-2","article-title":"Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium","volume":"11","author":"Boemer F","year":"2021","unstructured":"Boemer F, Caberg JH, Beckers P, et al.. Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Sci Rep. 2021, 11:10.1038\/s41598-021-99496-2","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre S","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, et al.. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995, 80:155-65. 10.1016\/0092-8674(95)90460-3","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2015.16","article-title":"A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing","volume":"60","author":"Kubo Y","year":"2015","unstructured":"Kubo Y, Nishio H, Saito K. A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing. J Hum Genet. 2015, 60:233-9. 10.1038\/jhg.2015.16","journal-title":"J Hum Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth B","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000, 15:228-37. 10.1002\/(SICI)1098-1004(200003)15:3&lt;228::AID-HUMU3&gt;3.0.CO;2-9","journal-title":"Hum Mutat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318220d523","article-title":"Technical standards and guidelines for spinal muscular atrophy testing","volume":"13","author":"Prior TW","year":"2011","unstructured":"Prior TW, Nagan N, Sugarman EA, Batish SD, Braastad C. Technical standards and guidelines for spinal muscular atrophy testing. Genet Med. 2011, 13:686-94. 10.1097\/GIM.0b013e318220d523","journal-title":"Genet Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D'Amico A","year":"2011","unstructured":"D'Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011, 6:10.1186\/1750-1172-6-71","journal-title":"Orphanet J Rare Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"Finkel RS","year":"2014","unstructured":"Finkel RS, McDermott MP, Kaufmann P, et al.. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 2014, 83:810-7. 10.1212\/WNL.0000000000000741","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008166","article-title":"Long-term progression in type II spinal muscular atrophy: a retrospective observational study","volume":"93","author":"Mercuri E","year":"2019","unstructured":"Mercuri E, Lucibello S, Pera MC, et al.. Long-term progression in type II spinal muscular atrophy: a retrospective observational study. Neurology. 2019, 93:1241-7. 10.1212\/WNL.0000000000008166","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(96)00284-5","article-title":"A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients","volume":"146","author":"Zerres K","year":"1997","unstructured":"Zerres K, Rudnik-Sch\u00f6neborn S, Forrest E, et al.. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997, 146:67-72. 10.1016\/s0022-510x(96)00284-5","journal-title":"J Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2021.100878","article-title":"Spinal muscular atrophy","volume":"37","author":"Nicolau S","year":"2021","unstructured":"Nicolau S, Waldrop MA, Connolly AM, Mendell JR. Spinal muscular atrophy. Semin Pediatr Neurol. 2021, 37:10.1016\/j.spen.2021.100878","journal-title":"Semin Pediatr Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2016.00007","article-title":"Copy number variations in the survival motor neuron genes: implications for spinal muscular atrophy and other neurodegenerative diseases","volume":"3","author":"Butchbach ME","year":"2016","unstructured":"Butchbach ME. Copy number variations in the survival motor neuron genes: implications for spinal muscular atrophy and other neurodegenerative diseases. Front Mol Biosci. 2016, 3:10.3389\/fmolb.2016.00007","journal-title":"Front Mol Biosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.141","article-title":"SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR","volume":"3","author":"Stabley DL","year":"2015","unstructured":"Stabley DL, Harris AW, Holbrook J, et al.. SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR. Mol Genet Genomic Med. 2015, 3:248-57. 10.1002\/mgg3.141","journal-title":"Mol Genet Genomic Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2020.09.005","article-title":"Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene","volume":"43","author":"Niba ET","year":"2021","unstructured":"Niba ET, Nishio H, Wijaya YO, et al.. Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene. Brain Dev. 2021, 43:294-302. 10.1016\/j.braindev.2020.09.005","journal-title":"Brain Dev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the Phase 2 NURTURE study","volume":"29","author":"De Vivo DC","year":"2019","unstructured":"De Vivo DC, Bertini E, Swoboda KJ, et al.. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the Phase 2 NURTURE study. Neuromuscul Disord. 2019, 29:842-56. 10.1016\/j.nmd.2019.09.007","journal-title":"Neuromuscul Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel RS","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, et al.. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017, 377:1723-32. 10.1056\/NEJMoa1702752","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri E","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, et al.. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018, 378:625-35. 10.1056\/NEJMoa1710504","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S239603","article-title":"Spinal muscular atrophy: mutations, testing, and clinical relevance","volume":"14","author":"Keinath MC","year":"2021","unstructured":"Keinath MC, Prior DE, Prior TW. Spinal muscular atrophy: mutations, testing, and clinical relevance. Appl Clin Genet. 2021, 14:11-25. 10.2147\/TACG.S239603","journal-title":"Appl Clin Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien YH","year":"2017","unstructured":"Chien YH, Chiang SC, Weng WC, et al.. Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J Pediatr. 2017, 190:124-9. 10.1016\/j.jpeds.2017.06.042","journal-title":"J Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.152","article-title":"Pilot study of population-based newborn screening for spinal muscular atrophy in New York state","volume":"20","author":"Kraszewski JN","year":"2018","unstructured":"Kraszewski JN, Kay DM, Stevens CF, et al.. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state. Genet Med. 2018, 20:608-13. 10.1038\/gim.2017.152","journal-title":"Genet Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200475","article-title":"Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening - opportunity or burden?","volume":"7","author":"M\u00fcller-Felber W","year":"2020","unstructured":"M\u00fcller-Felber W, Vill K, Schwartz O, et al.. Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening - opportunity or burden?. J Neuromuscul Dis. 2020, 7:109-17. 10.3233\/JND-200475","journal-title":"J Neuromuscul Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1515\/medgen-2020-2033","article-title":"Spinal muscular atrophy (5qSMA): best practice of diagnostics, newborn screening and therapy","volume":"32","author":"Eggermann K","year":"2020","unstructured":"Eggermann K, Gl\u00e4ser D, Abicht A, Wirth B. Spinal muscular atrophy (5qSMA): best practice of diagnostics, newborn screening and therapy. Med Genet. 2020, 32:263-72. 10.1515\/medgen-2020-2033","journal-title":"Med Genet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21173","article-title":"A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy","volume":"31","author":"Vezain M","year":"2010","unstructured":"Vezain M, Saugier-Veber P, Goina E, et al.. A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy. Hum Mutat. 2010, 31:1110-25. 10.1002\/humu.21173","journal-title":"Hum Mutat"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190468","article-title":"Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2","volume":"7","author":"Glascock J","year":"2020","unstructured":"Glascock J, Sampson J, Connolly AM, et al.. Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2. J Neuromuscul Dis. 2020, 7:97-100. 10.3233\/JND-190468","journal-title":"J Neuromuscul Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20230310-00372","article-title":"Expert consensus on newborn screening for spinal muscular atrophy (2023 edition). [Article in Chinese]","volume":"103","year":"2023","unstructured":"Expert consensus on newborn screening for spinal muscular atrophy (2023 edition). [Article in Chinese]. Zhonghua Yi Xue Za Zhi. 2023, 103.2075-81. 10.3760\/cma.j.cn112137-20230310-00372","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3680","article-title":"Ethical and policy issues in genetic testing and screening of children","volume":"131","author":"Fallat ME","year":"2013","unstructured":"Fallat ME, Katz AL, Mercurio MR, et al.. Ethical and policy issues in genetic testing and screening of children. Pediatrics. 2013, 131:620-2. 10.1542\/peds.2012-3680","journal-title":"Pediatrics"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijns8040059","article-title":"Parental depression and anxiety associated with newborn bloodspot screening for rare and variable-onset disorders","volume":"8","author":"Boychuk NA","year":"2022","unstructured":"Boychuk NA, Mulrooney NS, Kelly NR, Goldenberg AJ, Silver EJ, Wasserstein MP. Parental depression and anxiety associated with newborn bloodspot screening for rare and variable-onset disorders. Int J Neonatal Screen. 2022, 8:10.3390\/ijns8040059","journal-title":"Int J Neonatal Screen"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/children8080694","article-title":"Views of the general population on newborn screening for spinal muscular atrophy in Japan","volume":"8","author":"Lee T","year":"2021","unstructured":"Lee T, Tokunaga S, Taniguchi N, Fujino T, Saito M, Shimomura H, Takeshima Y. Views of the general population on newborn screening for spinal muscular atrophy in Japan. Children (Basel). 2021, 8:10.3390\/children8080694","journal-title":"Children (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.353","article-title":"Newborn genetic screening for spinal muscular atrophy in the UK: the views of the general population","volume":"6","author":"Boardman FK","year":"2018","unstructured":"Boardman FK, Sadler C, Young PJ. Newborn genetic screening for spinal muscular atrophy in the UK: the views of the general population. Mol Genet Genomic Med. 2018, 6:99-108. 10.1002\/mgg3.353","journal-title":"Mol Genet Genomic Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2012.08.002","article-title":"Parental attitudes on expanded newborn screening in Hong Kong","volume":"126","author":"Mak CM","year":"2012","unstructured":"Mak CM, Lam CW, Law CY, et al.. Parental attitudes on expanded newborn screening in Hong Kong. Public Health. 2012, 126:954-9. 10.1016\/j.puhe.2012.08.002","journal-title":"Public Health"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(22)00342-X","article-title":"Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study","volume":"7","author":"Kariyawasam DS","year":"2023","unstructured":"Kariyawasam DS, D'Silva AM, Sampaio H, Briggs N, Herbert K, Wiley V, Farrar MA. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study. Lancet Child Adolesc Health. 2023, 7:159-70. 10.1016\/S2352-4642(22)00342-X","journal-title":"Lancet Child Adolesc Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0820","article-title":"Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues","volume":"121","author":"Bailey Jr DB","year":"2008","unstructured":"Bailey Jr DB, Skinner D, Davis AM, Whitmarsh I, Powell C. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues. Pediatrics. 2008, 121:693-704. 10.1542\/peds.2007-0820","journal-title":"Pediatrics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3233\/JND-221510","article-title":"Newborn screening for SMA - can a wait-and-see strategy be responsibly justified in patients with four SMN2 copies?","volume":"9","author":"Blaschek A","year":"2022","unstructured":"Blaschek A, K\u00f6lbel H, Schwartz O, et al.. Newborn screening for SMA - can a wait-and-see strategy be responsibly justified in patients with four SMN2 copies?. J Neuromuscul Dis. 2022, 9:597-605. 10.3233\/JND-221510","journal-title":"J Neuromuscul Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho M","year":"2018","unstructured":"Calucho M, Bernal S, Al\u00edas L, et al.. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord. 2018, 28:208-15. 10.1016\/j.nmd.2018.01.003","journal-title":"Neuromuscul Disord"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-03-21-5924","article-title":"The changing therapeutic landscape of spinal muscular atrophy","volume":"51","author":"Davidson JE","year":"2022","unstructured":"Davidson JE, Farrar MA. The changing therapeutic landscape of spinal muscular atrophy. Aust J Gen Pract. 2022, 51:38-42. 10.31128\/AJGP-03-21-5924","journal-title":"Aust J Gen Pract"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2196\/38878","article-title":"The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): protocol for a longitudinal observational study","volume":"11","author":"Sahashi K","year":"2022","unstructured":"Sahashi K, Hashizume A, Kuwatsuka Y, Chinen M, Saotome-Nakamura A, Ando M, Katsuno M. The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): protocol for a longitudinal observational study. JMIR Res Protoc. 2022, 11:10.2196\/38878","journal-title":"JMIR Res Protoc"},{"key":"ref41","unstructured":"State of SMA. (2022). Accessed. December 12, 2024: https:\/\/www.curesma.org\/wp-content\/uploads\/2023\/06\/9062023_State-of-SMA_vWeb.pdf."},{"key":"ref42","unstructured":"Behind Spinraza's 95% price drop in China. desperate or pre-empted? (Part 1). (2022). Accessed: December 12, 2024: https:\/\/www.science-entrepreneur.com\/blog-posts\/behind-spinrazas-95-price-drop-in-china-desperate-or-pre-empted-part-1."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/287090-views-of-the-public-and-healthcare-professionals-on-newborn-screening-for-spinal-muscular-atrophy-and-the-potential-for-detecting-adult-onset-types-in-patients-in-waiting-in-hong-kong","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T04:21:16Z","timestamp":1739852476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/287090-views-of-the-public-and-healthcare-professionals-on-newborn-screening-for-spinal-muscular-atrophy-and-the-potential-for-detecting-adult-onset-types-in-patients-in-waiting-in-hong-kong"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.79190","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}